Certara to Present at the Barclays Global Healthcare Conference

PRINCETON, N.J.--(BUSINESS WIRE)--Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that William Feehery, CEO and Andrew Schemick, CFO will virtually present at the Barclays Global Healthcare Conference on Tuesday, March 9, 2021 at 11:30 a.m. ET.

A live webcast will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for 90 days thereafter.

About Certara

Certara accelerates medicines using biosimulation software and technology to transform traditional drug discovery and development. Its clients include more than 1,650 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 61 countries.